Santa Fe News Online

World Dupuytrens Contracture Market 2017 Revenue, Shares, Analysis and Forecasts till 2023

World Dupuytrens Contracture Market 2017 Revenue, Shares, Analysis and Forecasts till 2023

Dupuytrens Contracture Market
The Global Dupuytrens Contracture Market has been segmented on the basis of types, diagnosis, surgery, drugs, therapy and end users. The report explores comprehensive analysis of the market with respect to various countries in the four main geographies– the Americas, Europe, Asia Pacific, and Middle East & Africa.

The Dupuytrens Contracture market drivers increase in risk factors rising incomes, growing screening, increasing geriatric population etc. The market restraints are cost of Dupuytrens Contracture surgery, complications and risk of the surgery, invasive nature of treatment, and regression of the disease even after treatment etc.

The World Dupuytrens Contracture Market report provides segmentation by condition, diagnosis, treatment, end user, and its sub-segments. The report also provide a detailed analysis of global Dupuytrens Contracture market mainly based on Value Chain Analysis, Porter’s Five Forces, Price Analysis, and Supply Chain Analysis etc.

The Dupuytren’s contracture is a condition in which there is difficulty in articulating fingers due to formation of tissue knots under the skin. In severe conditions, the fingers become permanently bent in a flexed position. Dupuytren’s contracture is typically not painful and generally affects the ring finger followed by the little and middle fingers.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/4401 .

Key Players in the Global Dupuytrens Contracture Market:

Bristol-Meyers Squibb Co.,

Fresenius Kabi AG,

Merck Sharp & Dohme Corp.,

Pfizer Inc.,

West-Ward Pharmaceuticals,

Spear Pharmacueticals,

Actiza Pharmaceutical Private Limited,

Nantong Jinghua Pharmaceutical Co. Ltd.,

Endo International plc, and

Others

The Global Dupuytrens Contracture Market is expected to reach USD 5.5 billion by 2023, and the market is projected to grow at a CAGR of ~ 4.4 % during the forecast period 2017-2023.

The exact causes of Dupuytren’s contracture are unknown; however, the risk factors include alcoholism, smoking, thyroid problems, liver disease, diabetes, previous hand trauma, epilepsy, family history etc. Dupuytren’s contracture has a higher rate in males over the age of 50. There is also a genetic propensity with Caucasians being affected more while it is rare among Asians and Africans. Dupuytren’s contracture has a regress rate of approximately 10% of patients. The less severe forms of the disease are treated with steroid treatment and physiotherapy while surgery is usually performed when the metacarpophalangeal joint contracture exceeds 40 degrees or when the proximal interphalangeal joint contracture exceeds 20 degrees.

The annual incidence proportion was estimated at about 3 cases per 10,000 adults. The occurrence rate of this condition in the United States is about 5% of people, while Scandinavian nations have a higher rate of about 30% of men over 60 years old having the condition.

Regional Analysis: Europe accounted for a significant market share owing to extensive use of medications and high expenditure on the health care. Additionally, the greater prevalence of Dupuytrens Contracture in Europe drives the Dupuytrens Contracture market. Also, concentration of major research companies in the developed countries of this region is adding fuel to the market growth. The highly developed healthcare system of the Scandinavian countries coupled with high expenditure on healthcare, cruises the sale of Dupuytrens Contracture treatment. Europe is led by countries such as Germany and France with Norway, expected to be the fastest growing market.

US is the second largest market in the world due to high income and healthcare penetration. The presence of large healthcare players in the US benefits the market coupled with the high public expenditure on healthcare which comes to be approximately 16 % of the GDP. Asia Pacific region is expected to grow at a slower rate with China and India are likely to lead this market due to fast growing healthcare sector during the forecast period. The lower prevalence of Dupuytrens Contracture in the Asian populations acts as a drag on the market.

Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East & African market. The development of large hospitals such as the King Fahd hospital in Riyadh is driving the market. The African region is expected to witness a moderate growth owing to poor economic and political conditions and poor healthcare development. Also, the lower prevalence of Dupuytrens Contracture in the Asian populations acts as a drag on the market.

Get Discount @ https://www.marketresearchfuture.com/check-discount/4401 .

Table of Contents

Introduction

1 Definition

2 Scope of Study

2.1 Research Objective

2.2 Assumptions & Limitations

2.2.1 Assumptions

2.2.2 Limitations

3 Market Structure

2. Research Methodology

2.1 Research Process

2.2 Primary Research

2.3 Secondary Research

3. Market dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Macroeconomic Indicators

…Continued

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Media Contact
Company Name: Market Research Future
Contact Person: Akash Anand
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/dupuytren-s-contracture-market-4401

Calendar

November 2017
M T W T F S S
« Oct    
 12345
6789101112
13141516171819
20212223242526
27282930